“It has been widely reported that the SARS-CoV-2 virus, like all viruses, is mutating. Some of the mutational variants, with mutations that mainly occur in the virus spike protein, appear to have biological differences that may alter infectivity, transmission, and severity of infection. The Ii-Key vaccine platform is built to address issues of mutation. First, there are multiple Ii-Key-SARS-CoV-2 peptides, each containing multiple epitopes in the vaccine formulation. So even if there is one mutation, the other epitopes should provide protection. Second, if a new strain emerges, the Ii-Key platform can be rapidly deployed to make the new, mutant sequence with Ii-Key and add it to the current vaccine. This is the beauty of the Ii-Key technology. Further, the epitopes predicted by computational algorithms exclude regions of the coronavirus that are susceptible to mutation, so the Ii-Key vaccine largely eliminates mutagenic regions from the start.”

https://www.globenewswire.com/news-release/20...ccine.html